Profile data is unavailable for this security.
About the company
Zhaoke Ophthalmology Ltd is a China-based investment holding company principally engaged in the development, manufacturing and marketing of ophthalmic drugs. The Company’s products include innovative drugs and generic drugs. The Company ‘s products are mainly applied in five ophthalmic indications, including dry eye disease (DED), wet age-related macular degeneration (wAMD), diabetic macular edema (DME), myopia and glaucoma.
- Revenue in HKD (TTM)62.96m
- Net income in HKD-249.88m
- Incorporated2020
- Employees297.00
- LocationZhaoke Ophthalmology LtdNo. 1 Meide 3rd Road, Pearl RiverIndustrial Park, Nansha DistrictGUANGZHOU ChinaCHN
- Phone+86 2 039062888
- Websitehttps://www.zkoph.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transcenta Holding Ltd | 24.57m | -394.69m | 435.48m | 200.00 | -- | 0.4076 | -- | 17.72 | -0.9719 | -0.9719 | 0.0605 | 2.45 | 0.0131 | 0.8106 | 0.5768 | 114,292.40 | -21.08 | -- | -29.77 | -- | 26.02 | -- | -1,606.19 | -- | 1.04 | -31.65 | 0.2826 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
| Uni-Bio Science Group Ltd | 508.40m | 98.86m | 474.60m | 458.00 | 4.85 | 1.50 | 3.99 | 0.9335 | 0.0159 | 0.0159 | 0.0812 | 0.0514 | 1.27 | 2.23 | 9.05 | 1,249,140.00 | 24.76 | 1.46 | 32.97 | 1.97 | 83.51 | 80.59 | 19.44 | 1.23 | 2.17 | 168.55 | 0.2267 | 0.00 | 10.08 | 29.08 | 84.04 | -- | 84.98 | -- |
| Tianda Pharmaceuticals Ltd | 384.68m | -47.26m | 509.56m | 695.00 | -- | 0.9358 | -- | 1.32 | -0.022 | -0.022 | 0.1789 | 0.2533 | 0.4341 | 2.97 | 4.46 | 445,745.10 | -5.34 | -- | -7.97 | -- | 45.83 | -- | -12.30 | -- | 0.6748 | -9.51 | 0.1536 | -- | -- | -- | -- | -- | -- | -- |
| 3D Medicines Inc | 537.94m | -494.91m | 648.10m | 198.00 | -- | 0.6946 | -- | 1.20 | -2.10 | -2.10 | 2.25 | 3.61 | 0.3746 | 4.94 | 5.79 | 2,716,869.00 | -37.27 | -- | -50.88 | -- | 91.97 | -- | -99.50 | -- | 2.56 | -- | 0.2517 | -- | 11.91 | -- | 48.78 | -- | -- | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.20bn | 63.06m | 694.83m | 1.06k | 11.02 | 0.4055 | 3.54 | 0.5795 | 0.1071 | 0.1071 | 2.04 | 2.91 | 0.4403 | 2.11 | 9.70 | 1,134,410.00 | 1.98 | 13.33 | 2.52 | 17.76 | 51.49 | 61.92 | 4.50 | 36.20 | 0.7425 | 6.12 | 0.132 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 923.31m | 188.89m | 728.33m | 678.00 | 3.86 | 0.4176 | 5.75 | 0.7888 | 0.3372 | 0.3372 | 1.65 | 3.11 | 0.3574 | 2.10 | 2.94 | 1,088,814.00 | 7.31 | 7.67 | 10.25 | 10.48 | 75.46 | 78.79 | 20.46 | 20.68 | 1.62 | -- | 0.0502 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Zhaoke Ophthalmology Ltd | 62.96m | -249.88m | 737.29m | 297.00 | -- | 0.3295 | -- | 11.71 | -0.4587 | -0.4587 | 0.1155 | 4.10 | 0.0233 | 1.25 | 0.8868 | 201,164.90 | -9.23 | -- | -10.51 | -- | 82.03 | -- | -396.86 | -- | 5.48 | -24.02 | 0.1114 | -- | -- | -- | 5.47 | -- | -- | -- |
| Jbm (Healthcare) Ltd | 648.42m | 130.46m | 739.80m | 279.00 | 6.08 | 0.7707 | 4.03 | 1.14 | 0.1479 | 0.1479 | 0.7338 | 1.17 | 0.4645 | 4.25 | 5.98 | 2,324,068.00 | 9.83 | 4.38 | 12.04 | 5.52 | 52.14 | 46.47 | 21.16 | 12.69 | 1.25 | 89.68 | 0.1155 | 32.98 | 24.62 | 16.09 | 128.51 | 19.99 | 2.26 | -- |
| Fusen Pharmaceutical Co Ltd | 468.25m | -98.69m | 749.96m | 1.14k | -- | 1.31 | -- | 1.60 | -0.1324 | -0.1324 | 0.6286 | 0.7637 | 0.3212 | 1.68 | 3.35 | 407,884.50 | -6.77 | 0.9678 | -13.96 | 1.74 | 53.18 | 51.95 | -21.08 | 2.59 | 0.526 | -2.27 | 0.4031 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.25bn | 122.50m | 777.24m | 2.74k | 6.22 | 0.6382 | 3.70 | 0.3456 | 0.1447 | 0.1447 | 2.66 | 1.41 | 1.09 | 2.68 | 6.10 | 851,042.60 | 5.99 | 7.69 | 9.17 | 11.75 | 57.55 | 60.44 | 5.49 | 6.73 | 0.9033 | 43.87 | 0.1516 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| Pak Fah Yeow International Ltd | 265.21m | 96.45m | 810.26m | 101.00 | 8.40 | 1.08 | 7.81 | 3.06 | 0.3094 | 0.3094 | 0.8507 | 2.41 | 0.2869 | 2.84 | 23.53 | 2,600,118.00 | 10.44 | 3.99 | 11.32 | 4.18 | 87.05 | 80.79 | 36.37 | 21.27 | 4.22 | 5.26 | 0.0055 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Hbm Holdings Ltd | 562.69m | 165.98m | 944.92m | 177.00 | 5.45 | 0.9406 | 4.81 | 1.68 | 0.2256 | 0.2256 | 0.7632 | 1.31 | 0.3258 | 3.96 | 16.67 | 3,179,066.00 | 9.59 | -54.61 | 13.25 | -66.04 | 95.57 | 97.81 | 29.42 | -400.28 | 3.44 | 8.14 | 0.3502 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Ascletis Pharma Inc | 11.10m | -284.45m | 1.04bn | 219.00 | -- | 0.439 | -- | 93.42 | -0.274 | -0.274 | 0.0107 | 2.37 | 0.0041 | 1.34 | 3.58 | 50,703.01 | -10.47 | -6.43 | -10.85 | -6.64 | -125.17 | 35.67 | -2,561.69 | -243.38 | 24.31 | -4.18 | 0.004 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
Data as of Sep 20 2024. Currency figures normalised to Zhaoke Ophthalmology Ltd's reporting currency: Hong Kong Dollar HKD
7.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Hong Kong) Ltd.as of 31 May 2024 | 35.78m | 6.55% |
| GIC Pte Ltd. (Investment Management)as of 31 Dec 2023 | 5.13m | 0.94% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.00m | 0.18% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 525.50k | 0.10% |
| SSgA Funds Management, Inc.as of 05 Sep 2024 | 218.88k | 0.04% |
| Amundi (UK) Ltd.as of 31 Jul 2024 | 192.50k | 0.04% |
| Amundi Hong Kong Ltd.as of 30 Jun 2023 | 63.50k | 0.01% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 47.00k | 0.01% |
| Janus Henderson Investors US LLCas of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 11 Sep 2024Source: FactSet Research Systems Inc.
